NCI’s Dawsey Retires After 35 Years
Dr. Sanford Dawsey, senior investigator in the Metabolic Epidemiology Branch (MEB) retired in August after more than 35 years of service to the National Cancer Institute. He is best known for his research on methods of prevention and control of esophageal squamous cell carcinoma (ESCC), including etiologic studies of ESCC in high-risk populations and the development of clinically useful techniques for the early detection and treatment of ESCC precursor lesions and early invasive tumors.
A pathologist by training, Dawsey has conducted numerous field studies of ESCC in high-risk countries around the world, including China, Iran, Brazil and Kenya. He and his collaborators identified important potentially modifiable risk factors for ESCC, including low serum selenium, exposure to high levels of polycyclic aromatic hydrocarbons (PAHs), poor oral hygiene and drinking scalding hot beverages such as tea and maté, a widely consumed tea-like beverage used in Southern South America that is often heavily contaminated with PAHs.
In addition, Dawsey led multiple studies that conclusively proved that HPV is not the cause of high rates of ESCC in these high-risk regions, which was very important since it means we cannot rely on the HPV vaccine to reduce the burden of ESCC in these populations.
In partnership with colleagues in China and the U.S., Dawsey developed an endoscopic early detection and treatment program that has been shown to reduce ESCC mortality significantly in high-risk areas of China. Today, this program screens more than 200,000 adults annually in China.
He was also instrumental in the establishment of the African Esophageal Cancer Consortium (AfrECC), a network of programs that perform coordinated etiologic, early detection and treatment and palliation studies of ESCC in Eastern and Southern Africa. He plans to continue making major contributions to AfrECC in retirement as an NCI special volunteer.
Dawsey received his medical degree from Stanford University, completed his residency in pathology at the University of Colorado, Denver, and completed a fellowship in cytology at the University of California, Los Angeles.
In the 1980s, he served as the first pathologist at the McCormick Hospital in Chiang Mai, Thailand, where he helped start the first Pap screening program in Northern Thailand; he also served as a staff pathologist at Saint Joseph Hospital in Denver. He joined NCI in 1987 to work on the Nutrition Intervention Trials in Linxian, China, which has the highest rates of ESCC in the world.
Over the course of his career, Dawsey trained dozens of fellows locally and remotely in the U.S., China, Iran, Kenya and Malawi. In 2011, he received the NIH Ruth L. Kirschstein Mentoring Award for “exemplary performance while demonstrating significant leadership, skill and ability in serving as a mentor.” In 2018, he received the DCEG Exemplary Service Award for his outstanding research on esophageal cancer.